Nasdaq

Cepheid's (CPHD) Xpert HIV Test Wins CE-IVD Mark in Europe - Analyst Blog

In an attempt to strengthen its foothold in the virology market, molecular diagnostics corporation Cepheid ( CPHD), together with the not-for-profit organization - Foundation for Innovative New ...
Houston Chronicle

(PRN) Cepheid's Xpert(TM) EV Test for Enteroviral Meningitis Gains Adoption at Approximately 20 Leading U.S. Medical Centers

Managing One of the Largest Enterovirus Testing Populations, Children's Medical Center Dallas Among Leading Institutions to Quickly Adopt Cepheid's SUNNYVALE, Calif ...
Nasdaq

Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test

SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...
Business Insider

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox

SUNNYVALE, Calif., Feb. 14, 2023 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert Mpox, which runs on ...
Seeking Alpha

Cepheid Receives FDA Clearance for Xpert® Xpress GBS

Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females Group B Streptococcus (GBS) is the leading cause of ...